HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,302.35
Day range
₹1,287.30 - ₹1,320.00
Year range
₹809.15 - ₹1,522.05
Market cap
179.65B INR
Avg Volume
213.67K
P/E ratio
51.61
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 7.39B | 47.64% |
Operating expense | 3.69B | 38.14% |
Net income | 915.90M | -25.80% |
Net profit margin | 12.39 | -49.76% |
Earnings per share | 6.72 | -25.83% |
EBITDA | 2.62B | 45.25% |
Effective tax rate | 25.37% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.43B | 27.24% |
Total assets | 70.22B | 81.20% |
Total liabilities | 38.45B | 165.59% |
Total equity | 31.77B | — |
Shares outstanding | 136.09M | — |
Price to book | 6.40 | — |
Return on assets | — | — |
Return on capital | 7.72% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 915.90M | -25.80% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,620
